Warning letters, 483s, Recalls, Import Alerts, Audit observations
FDA issued a Warning letter to Amman Pharmaceuticals following inspection at the facility (FEI 3013501887)
USFDA audit of Eugia US Manufacturing in New Jersey, US (FEI 3015534630) resulted in issuance
USFDA Inspected Indian drug manufacturer Kilitch facility in Mumbai (FEI 3011853060) in Oct 2023. USFDA
Panacea Biotec, Baddi facility was inspected by USFDA in Oct 2023- investigators Sandra A Boyd
The USFDA Warning letter to K. C. Pharmaceuticals issued in August 2023, following inspection at
Biocon Malaysia was inspected by USFDA Investigators Eileen A. Liu, Patty P. Kaewussdangkul, Daniel Lahar,
USFDA 483 to Intas cites lapses in investigation and review of failures and discrepancies in
FDA published the USFDA483 issued to Intas site (FEI 3003157498) in Ahmedabad, India after inspection
